
|Articles|January 1, 2004
KTP laser shows high efficacy in men with retention
Author(s)Alison Palkhivala
Montreal--Using a high-powered potassium titanyl phosphate (KTP) laser to vaporize prostate tissue is proving to be safe and effective as a treatment for urinary retention in men.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Integration of doublet and triplet therapy in metastatic prostate cancer
4
Sarah Azari, MD, on early sexual health education for women with bladder cancer
5






